System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Francisco Marín is an expert in Cardiology at Hospital Universitario Virgen de la Arrixaca (Spain). As of October 2026, ScienceLeadR ranks Francisco Marín in the top 1% of experts worldwide for Atrial Fibrillation, Embolism and Thrombosis and Myocardial Ischemia. Francisco Marín has authored 753 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 5 of them ongoing. SLR score: 2,072 (community average: 125). How the SLR is computed.

LeadR Profile

Francisco Marín Hospital Universitario Virgen de la Arrixaca Spain
2 072 ScienceLeadR Reputation 2072

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Nutrition - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026
Source: PubMed

University of Murcia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 753

Citations

Citations: 27 550 1st author: 55 Last author: 154 Unique author: 6

Main journals

Rev Esp Cardiol 79
Rev Esp Cardiol (Engl Ed) 60
Thromb Haemost 41
Europace 39
Int J Cardiol 24

Best Journals

Eur Heart J 8
Circulation 3
N Engl J Med 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Integrated care management and comprehensive geriatric assessment using a mHealth-based approach in older multimorbid patients with atrial fibrillation: the AFFIRMO cluster-randomised trial.
PMID 42819749 — atrial fibrillation, geriatric assessment		Lancet Reg Health Eur20260
AI-Based Phenotyping of Atrial Fibrillation Through Generative Topographic Mapping: Prospective Murcia Atrial Fibrillation Project III Cohort Study.
PMID 42562389 — information services, comorbidity, hemorrhage, phenotype, cohort studies, atrial fibrillation, cluster analysis, artificial intelligence		J Med Internet Res20260
New opportunities and challenges in anticoagulation.
PMID 42102914 — cardiovascular diseases		Rev Esp Cardiol (Engl Ed)20260
Adjunctive Intra-Arterial Alteplase After Successful Thrombectomy for Acute Ischemic Stroke: The CHOICE-2 Randomized Clinical Trial.
PMID 42096239 — hemorrhage, ischemic stroke, stroke, tissue plasminogen activator, intracranial hemorrhages, thrombectomy		JAMA Top journal20260
Impact of seasonal temperature variations on adverse outcomes in atrial fibrillation: comparative insights from Vigo and Murcia cohorts.
PMID 41990305 — ischemic stroke, stroke, incidence, global health, atrial fibrillation, cities, temperature		J Glob Health20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 6
N/A 5
Phase 4 1

By status:

Completed 6
Active not recruiting 3
Recruiting 3

By type:

Interventional 9
Observational 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 1
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Evaluation of efficacy and safety of early in hospital initiation of inclisiran treatment in patients with acute coronary syndromes
2025-521670-34-00 — safety, myocardial infarction, acute coronary syndrome, st elevation myocardial infarction, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, non-st elevated myocardial infarction		Phase 3Recruiting2026
A Trial to Test How AZD0780 Affects Serious Heart Stroke or Vascular Problems in Patients with Heart Stroke or Vascular Disease or at High Risk for Such Issues
2025-520519-14-00 — stroke, heart, cardiovascular diseases, vascular diseases		Phase 3Recruiting2025
A Phase 3 Randomized Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of MK 0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
2022-502781-24-01 — heart diseases, safety, heart, cardiovascular diseases, coronary disease		Phase 3Active not recruiting2024
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028 — diabetes mellitus, exercise, hypertension, stroke, ischemic attack, transient, heart failure, pharmaceutical preparations, heart, atrial fibrillation, diet, pulmonary disease, chronic obstructive, vascular diseases, peripheral vascular diseases, peripheral arterial disease, therapeutics		N/ARecruiting2024
CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2)
NCT05797792 — embolectomy, ischemic stroke, stroke, plasminogen, plasminogen activators, tissue plasminogen activator, reperfusion, tissues, thrombectomy		Phase 3Active not recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS